Cholecystectomy Surgery in India and UAE | Complete Patient Guide

• IDEAL SURGICAL CANDIDATES:

• Symptomatic cholelithiasis (gallstones causing recurrent biliary colic or acute cholecystitis)

• Acute cholecystitis (TG18 Grade I or II; Grade III with optimization of organ dysfunction)

• Choledocholithiasis after endoscopic common bile duct clearance via ERCP

• Biliary dyskinesia confirmed by HIDA scan with gallbladder ejection fraction <35%

• Gallbladder polyps ≥10 mm, rapidly enlarging polyps, or polyps in patients with primary sclerosing cholangitis (any size)

• Porcelain gallbladder with associated mucosal irregularity

• Gallstone pancreatitis (index admission or post-resolution laparoscopic cholecystectomy within 4–6 weeks)

• Asymptomatic gallstones in high-risk subgroups: patients with sickle cell disease, candidates for bariatric surgery, or immunocompromised individuals

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Abdominal ultrasound (first-line imaging for gallstone detection, wall thickening, pericholecystic fluid)

• Liver Function Tests (LFTs): ALT, AST, ALP, GGT, total and direct bilirubin

• Complete Blood Count (CBC) and C-Reactive Protein (CRP) for inflammatory stratification

• Serum amylase and lipase (to rule out concurrent pancreatitis)

• MRCP (Magnetic Resonance Cholangiopancreatography) or EUS (Endoscopic Ultrasound) when choledocholithiasis or biliary stricture is suspected

• CT Abdomen with contrast in complex or atypical presentations to assess for empyema, perforation, or Mirizzi syndrome

• HIDA (Hepatobiliary Iminodiacetic Acid) scan for biliary dyskinesia evaluation

• Cardiac evaluation (ECG, ECHO if indicated) and pulmonary function for patients with significant cardiorespiratory comorbidity

• Coagulation profile (PT/INR) — mandatory; anticoagulants must be bridged per protocol

• RELATIVE OR ABSOLUTE CONTRAINDICATIONS:

• Uncontrolled coagulopathy not correctable pre-operatively

• Severe, decompensated cirrhosis (Child-Pugh Class C) — significantly elevated hemorrhagic and hepatic decompensation risk

• Suspected gallbladder carcinoma requiring oncological staging and potential radical cholecystectomy with hepatic resection (not a contraindication to surgery per se, but alters operative planning)

• Pregnancy (first trimester and third trimester are relatively contraindicated; second trimester is preferred window if surgery is mandatory)

• Multiple prior upper abdominal surgeries with dense adhesions (increases conversion risk; not an absolute contraindication)

• Active, uncontrolled systemic infection requiring stabilization prior to elective surgery

LAPAROSCOPIC CHOLECYSTECTOMY (Standard of Care): The four-port laparoscopic approach — utilizing a 10 mm umbilical port for the 30-degree HD camera and three 5 mm working ports — remains the global gold standard. The critical surgical principle is achieving the Critical View of Safety (CVS), as defined by Strasberg's criteria: dissection of the hepatocystic triangle to expose two and only two structures entering the gallbladder (the cystic duct and cystic artery), with the lower third of the gallbladder separated from the liver bed. Adherence to CVS has reduced major bile duct injury rates to 0.1–0.3% in experienced centers. Pneumoperitoneum is established at 12–15 mmHg CO2. Operative time is typically 30–60 minutes in uncomplicated cases.

SINGLE-INCISION LAPAROSCOPIC CHOLECYSTECTOMY (SILC / SILS): Performed through a single 2–3 cm umbilical incision using a multi-channel port, SILC offers superior cosmesis (essentially scarless) with comparable safety to the standard four-port technique in selected patients. It requires advanced laparoscopic skill and articulating instruments. It is offered at select high-volume centers in India (Apollo, Fortis, Manipal) and UAE (Cleveland Clinic Abu Dhabi, Mediclinic City Hospital Dubai).

ROBOTIC-ASSISTED CHOLECYSTECTOMY (da Vinci Surgical System): Robotic cholecystectomy — performed on the da Vinci Xi or da Vinci SP platform — provides 3D magnified visualization, wristed instrument articulation (7 degrees of freedom), and tremor filtration. It is particularly advantageous in morbidly obese patients, patients with prior abdominal surgeries, and in cases where concomitant common bile duct exploration or hepatic procedures are anticipated. Robotic platforms are available at JCI-accredited institutions in both India and the UAE. Cost is higher than standard laparoscopy.

INTRAOPERATIVE CHOLANGIOGRAPHY (IOC) & ICG FLUORESCENCE CHOLANGIOGRAPHY: IOC involves cannulation of the cystic duct and contrast injection to visualize the biliary tree under fluoroscopy — the historical gold standard for real-time biliary mapping. Near-infrared fluorescence cholangiography with intravenous Indocyanine Green (ICG, administered 30–60 minutes pre-operatively) provides continuous, real-time, fluorescence-guided visualization of the extrahepatic bile ducts without radiation. ICG cholangiography is now routinely employed at leading centers in India and the UAE, particularly in acute or previously inflamed gallbladder cases.

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) — PRE-OPERATIVE: When choledocholithiasis (common bile duct stones) is confirmed or strongly suspected (elevated bilirubin, dilated CBD on imaging), ERCP with sphincterotomy and stone extraction is performed prior to or concurrent with laparoscopic cholecystectomy. This two-stage approach — ERCP followed by interval laparoscopic cholecystectomy — is the standard management protocol at hepatobiliary centers in both destinations.

OPEN CHOLECYSTECTOMY (Kocher's Subcostal Incision): Primary open cholecystectomy is reserved for cases with suspected gallbladder carcinoma requiring radical resection, cases with frozen hepatocystic triangle anatomy where laparoscopic dissection poses unacceptable risk, or emergency damage control situations. Conversion from laparoscopic to open (conversion rate: 2–5% in elective cases, up to 15–30% in acute/gangrenous cholecystitis) is performed without hesitation when patient safety demands it — this is a sound surgical decision, not a complication.

PERCUTANEOUS CHOLECYSTOSTOMY (Bridge Therapy): In critically ill patients with Grade III acute cholecystitis (TG18) who are unfit for immediate surgery — due to cardiovascular instability, respiratory failure, or severe coagulopathy — percutaneous ultrasound- or CT-guided cholecystostomy tube drainage provides temporizing biliary decompression. Interval laparoscopic cholecystectomy is subsequently planned after physiological optimization (typically 4–8 weeks).

PRE-OPERATIVE PHASE (Days 1–5 in destination country):

• Day 1: Airport arrival; GAF Healthcare coordinator meets patient. Transfer to accommodation or hospital. Administrative registration and orientation.

• Day 1–2: Comprehensive pre-operative workup — abdominal ultrasound, LFTs, CBC, CRP, coagulation profile, blood typing and crossmatch, ECG. MRCP or CT abdomen if indicated. Anesthesiology consultation and ASA risk classification. Surgeon consultation with review of all imaging and pathology from home country.

• Day 2–3: ERCP (if choledocholithiasis confirmed) performed as a separate, dedicated procedure under conscious sedation or general anesthesia. Patient observed for 24 hours post-ERCP for pancreatitis or bleeding.

• Day 3–5: Patient optimized — anticoagulants bridged, electrolytes corrected, blood glucose controlled in diabetic patients. Patient and attendant educated on procedure, recovery expectations, and warning signs. Informed consent obtained.

• Pre-operative fasting: Nil by mouth for solids 6–8 hours; clear fluids permitted until 2 hours prior to surgery per Enhanced Recovery After Surgery (ERAS) protocol.

INTRA-OPERATIVE PHASE (Day of Surgery):

• General anesthesia induced; Total Intravenous Anesthesia (TIVA) with propofol and remifentanil is increasingly preferred to reduce postoperative nausea and vomiting (PONV).

• Patient positioned supine with 20–30° reverse Trendelenburg and left lateral tilt (French position).

• Pneumoperitoneum established; ports placed per chosen technique (four-port standard, SILC, or robotic).

• Critical View of Safety (CVS) achieved before any clipping or division.

• ICG fluorescence cholangiography performed to confirm biliary anatomy.

• Cystic duct and cystic artery doubly clipped with titanium or absorbable polymer clips and divided.

• Gallbladder dissected off the liver bed using electrocautery hook or ultrasonic energy device (Harmonic scalpel / LigaSure).

• Specimen extracted in a retrieval bag via the umbilical port to prevent port-site tumor seeding and bile spillage.

• Ports closed in layers; local anesthetic infiltrated at port sites for immediate post-operative analgesia.

• Total operative time: 30–75 minutes (laparoscopic); 90–120 minutes (robotic or complex).

POST-OPERATIVE PHASE — HOSPITAL (Days 1–3):

• Recovery room: Vital sign monitoring, pain assessment using Numeric Rating Scale (NRS). IV analgesia with paracetamol ± ketorolac (NSAID). Anti-emetics administered prophylactically.

• ERAS protocol: Oral fluids offered 2–4 hours post-operatively. Early ambulation (within 6–8 hours of surgery). Urinary catheter removed same evening.

• Day 1 post-op: Light diet tolerated. IV fluids discontinued. Oral analgesics (paracetamol, NSAIDs). Surgeon ward round; wound inspection.

• Day 2 post-op: Soft diet. Patient mobile and self-caring. Liver function tests and CBC repeated if clinical concern.

• Day 2–3 post-op: Discharge decision based on pain control on oral analgesics, tolerance of diet, absence of fever, and normal bowel function. Discharge summary, prescription, and follow-up plan provided.

POST-OPERATIVE RECOVERY — OUTPATIENT (Weeks 1–2 in destination country):

• Days 3–7: Rest at GAF Healthcare partner accommodation. Wound dressing check at Day 5. Gradual increase in ambulation. Avoid strenuous activity, lifting >5 kg, and driving.

• Day 7: Surgical follow-up appointment. Wound review. If laparoscopic clips were used, no suture removal required (absorbable skin sutures or surgical glue). Symptom check — any jaundice, fever >38°C, worsening abdominal pain, or bile-colored drainage from a port site triggers urgent hepatobiliary evaluation.

• Week 2: Fit-to-fly assessment. Uncomplicated laparoscopic patients are generally cleared for short-haul flights (under 4 hours) at 7–10 days. Long-haul flights (>6 hours) are recommended after 2 weeks. Open cholecystectomy patients require 3–4 weeks before long-haul travel. DVT prophylaxis (compression stockings ± low-molecular-weight heparin) is prescribed for all flights.

LONG-TERM RECOVERY MILESTONES:

• 2 weeks: Return to desk/office work.

• 3–4 weeks: Return to light physical activity.

• 4–6 weeks: Full physical activity and exercise resumed (laparoscopic); 6–8 weeks (open).

• Dietary adjustment: Low-fat diet for 4–6 weeks post-operatively as the body adapts to continuous (rather than bolus) bile flow into the duodenum. Most patients return to a normal diet thereafter. A small proportion (5–10%) experience post-cholecystectomy syndrome (diarrhea, bloating) managed with dietary modification and bile acid sequestrants (cholestyramine) if persistent.